Page 296 - IJB-10-2
P. 296

International Journal of Bioprinting                              Kidney hydrogel print for renal cancer model













































            Figure 4. Biocompatibility tests of GelMA-Kidney hydrogel. (A) ACHN cellular morphology; (B) ACHN cellular proliferation; (C–L) Expression levels of
            an array of EMT-related markers in ACHN cells in various concentrations of GelMA-Kidney hydrogels.

               Next, Kyoto Encyclopedia of Genes and Genomes   compared to the 10% GelMA control, while CDH1 was
            (KEGG) enrichment analysis was also conducted to   downregulated. This observation was further verified
            analyze changes in signaling pathways of ACHN cells   by  the  quantification  of  immunofluorescence  intensity
            grown in 10% GelMA-2% Kidney cultures (Figure 5C).   using NIH ImageJ (Figure 6B–F). Here, the expression
            We identified several signaling pathways related to cancer   of vimentin, TWIST, CD44, CDH1, and CDH2 was
            development, including the VEGF (hsa04370), PPAR   up- or downregulated by 2.53-, 1.52-, 2.00-, 0.71-, and
            (hsa03320), PI3K-Akt (hsa04151), HIF-1 (hsa04066), and   2.11-folds, respectively.
            TGF-beta (hsa04350).
                                                               3.6. ACHN drug resistance
            3.5. Expression of EMT-related protein             Finally,  the  effect of  dECM  powders on  ACHN  drug
            To examine the effect of kidney dECM powder on     resistance was evaluated by assessing the resistance of the
            ACHN behavior, we evaluated the effect of the 10%
            GelMA-2% Kidney on EMT-related protein expression.   cells toward sunitinib on day 5 (Figure S2 in Supplementary
            Specifically, we tested for vimentin, TWIST, CD44,   File). The cellular viabilities of the 2D, 10% GelMA, and
            CDH1, and CDH2, by immunofluorescence staining on   10% GelMA-2% Kidney cultures were 36.40% ± 1.08%,
            day 5 of the 10% GelMA-2% Kidney treatment (Figure   40.19% ± 7.02%, and 46.41% ± 4.93%, respectively. ACHN
            6A). The result for secondary antibody assay is shown   cells  cultured in  GelMA-based hydrogels  all  showed
            in Figure S2K (Supplementary File), where no positive   significantly higher chemoresistance compared with 2D
            staining was observed, indicating the genuine positivity   cell cultures. Moreover, the inclusion of 2% kidney dECM
            in the fluorescence images. We found that the protein   powder significantly promoted cellular viability compared
            expression of vimentin, TWIST, CD44, and CDH2 was   to 10% GelMA, suggesting that kidney dECM powder can
            upregulated in the  10%  GelMA-2%  Kidney  culture   enhance the drug resistance of ACHN cells.


            Volume 10 Issue 2 (2024)                       288                                doi: 10.36922/ijb.1413
   291   292   293   294   295   296   297   298   299   300   301